J. Sloan

发表

Screening for lung cancer with low-dose spiral computed tomography.

S. Swensen, J. Jett, T. Hartman, 2000, American journal of respiratory and critical care medicine.

Screening for lung cancer with low-dose spiral computed tomography.

S. Swensen, J. Jett, T. Hartman, 2000, American journal of respiratory and critical care medicine.

Lung cancer screening with CT: Mayo Clinic experience.

S. Swensen, J. Jett, T. Hartman, 2003, Radiology.

A placebo‐controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome

P. Novotny, J. Sloan, C. Loprinzi, 2007, Cancer.

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy

P. Novotny, J. Sloan, C. Loprinzi, 2002, Pain.

Tamoxifen-associated hot flashes in women.

P. Novotny, J. Sloan, C. Loprinzi, 2007, Supportive cancer therapy.

Depomedroxyprogesterone acetate for hot flashes.

P. Novotny, J. Sloan, C. Loprinzi, 2002, Journal of pain and symptom management.

Tamoxifen-induced hot flashes.

P. Novotny, J. Sloan, C. Loprinzi, 2000, Clinical breast cancer.

Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.

P. Novotny, J. Sloan, C. Loprinzi, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Definitions of hot flashes in breast cancer survivors.

J. Sloan, C. Loprinzi, D. Barton, 1998, Journal of pain and symptom management.

A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma

J. Sloan, N. Foster, M. Aubry, 2008, Cancer.

Pilot evaluation of mirtazapine for the treatment of hot flashes.

P. Novotny, J. Sloan, C. Loprinzi, 2004, The journal of supportive oncology.

Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.

P. Novotny, J. Sloan, C. Loprinzi, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Levetiracetam for the treatment of hot flashes: a phase II study

A. Bardia, J. Sloan, C. Loprinzi, 2007, Supportive Care in Cancer.

Pilot evaluation of aprepitant for the treatment of hot flashes.

A. Bardia, J. Sloan, C. Loprinzi, 2006, Supportive cancer therapy.

Spiritual quality of life in advanced cancer patients receiving radiation therapy

M. Clark, T. Rummans, J. Sloan, 2014, Psycho-oncology.

The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9

P. Novotny, J. Sloan, C. Loprinzi, 2013, Supportive Care in Cancer.

Cerebral toxicity in patients treated for small cell carcinoma of the lung.

B. O'neill, R. Fonseca, J. Sloan, 1999, Mayo Clinic proceedings.

Randomized Phase II Study of Daily Versus Continuous-Infusion Schedules of Topotecan in the Treatment of Extensive-Stage Small Cell Lung Cancers

J. Sloan, R. Marks, J. Kugler, 2003, American journal of clinical oncology.

Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy.

E. Perez, J. Sloan, C. Loprinzi, 2010, Breast.

Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.

J. Sloan, C. Loprinzi, J. Kugler, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.

P. Novotny, J. Sloan, C. Loprinzi, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors

J. Sloan, L. Denis, S. Alberts, 2006, Cancer Chemotherapy and Pharmacology.

Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors.

J. Sloan, R. Diasio, R. Goldberg, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient assessment of bowel function during and after pelvic radiotherapy: results of a prospective phase III North Central Cancer Treatment Group clinical trial.

J. Sloan, G. Soori, J. Martenson, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254.

P. Novotny, J. Sloan, C. Loprinzi, 2016, The Lancet. Oncology.

Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy.

T. Sellers, D. Schaid, S. McDonnell, 2000, JAMA.

Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.

J. Sloan, C. Loprinzi, P. Atherton, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Calibration of quality-adjusted life years for oncology clinical trials.

D. Sargent, P. Novotny, H. Nelson, 2014, Journal of Pain and Symptom Management.

Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis.

P. Novotny, J. Sloan, J. Lovato, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration

P. Novotny, J. Sloan, C. Loprinzi, 2009, Menopause.

Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis

P. Novotny, A. Bardia, J. Sloan, 2009, Menopause.

Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience

P. Novotny, J. Sloan, C. Loprinzi, 2008, Menopause.

Phase II Evaluation of Desipramine for the Treatment of Hot Flashes.

T. Rummans, T. Shanafelt, J. Sloan, 2007, Supportive cancer therapy.

SAS® Tools for Cost Effective and High Quality Clinical Trial Reporting

P. Novotny, J. Sloan, N. Foster, 2012 .

Quality of life in hospice patients. A pilot study.

T. Rummans, J. Sloan, J. Sloan, 1999, Psychosomatics.

Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial.

P. Novotny, J. Sloan, C. Loprinzi, 2007, Mayo Clinic proceedings.

Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial

P. Novotny, J. Sloan, C. Loprinzi, 2006 .

Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients

J. Jett, J. Sloan, S. Hillman, 2003, Supportive Care in Cancer.

Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non‐small cell lung cancer

C. Patten, J. Sloan, R. Marks, 2002, Psycho-oncology.

A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.

J. Sloan, R. Marks, R. Goldberg, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.

J. Sloan, M. Goetz, A. Adjei, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

5‐year follow‐up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial

E. Perez, J. Sloan, C. Loprinzi, 2015, Cancer.

Patient-reported outcomes of catheter-based accelerated partial breast brachytherapy and whole breast irradiation, a single institution experience

Sean S. Park, J. Sloan, W. Harmsen, 2018, Breast Cancer Research and Treatment.

Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.

J. Sloan, C. Loprinzi, S. Dakhil, 2013, Journal of the National Cancer Institute.

Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC

E. Perez, J. Sloan, C. Loprinzi, 2009, Breast Cancer Research and Treatment.

Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma

E. Perez, P. Novotny, J. Sloan, 1997, Cancer.

Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials

A. Abyzov, N. Aaronson, J. Sloan, 2017, Supportive Care in Cancer.

The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA

N. Aaronson, J. Sloan, C. Loprinzi, 2012, Supportive Care in Cancer.

Further data supporting that paclitaxel‐associated acute pain syndrome is associated with development of peripheral neuropathy

P. Novotny, J. Sloan, C. Loprinzi, 2012, Cancer.

Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1.

P. Novotny, J. Sloan, C. Loprinzi, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial

J. Sloan, C. Loprinzi, K. Rowland, 2011, Supportive Care in Cancer.

Relationship of sensory symptoms and motor function in patients with chemotherapy-induced peripheral neuropathy (CIPN) utilizing the EORTC QLQ CIPN20: NCCTG study N06CA.

N. Aaronson, J. Sloan, C. Loprinzi, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Was it worth it (WIWI)? Patient satisfaction with clinical trial participation: Results from North Central Cancer Treatment Group (NCCTG) phase III trial N0147.

D. Sargent, E. Basch, J. Sloan, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Calibration of quality-adjusted life years (QALYs) for oncology clinical trials (OCT).

D. Sargent, P. Novotny, H. Nelson, 2010 .

A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

P. Novotny, J. Sloan, S. Dakhil, 2003, Cancer.

A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors

J. Sloan, R. Goldberg, S. Alberts, 2005, Cancer Chemotherapy and Pharmacology.

N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors

R. Vierkant, J. Olson, F. Couch, 2021, Journal of clinical medicine.

Pilot evaluation of bupropion for the treatment of hot flashes.

T. Rummans, P. Novotny, J. Sloan, 2006, Journal of palliative medicine.

A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer.

J. Jett, J. Sloan, J. Knost, 2000, Lung cancer.

Pilot evaluation of gabapentin for treating hot flashes.

E. Perez, P. Novotny, J. Sloan, 2002, Mayo Clinic proceedings.

Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes

J. Sloan, T. Pisansky, C. Loprinzi, 1998, Cancer.

Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy.

J. Sloan, C. Loprinzi, S. Okuno, 1999, American journal of clinical oncology.

Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy

J. Sloan, E. Galanis, S. Frytak, 1999, Cancer Immunology, Immunotherapy.

Whose opinion counts?

J. Sloan, C. Loprinzi, D. Barton, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting.

R. Hurt, P. Novotny, J. Sloan, 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

A phase III randomized trial of two different dosing schedules of erythropoietin (EPO) in patients with cancer-associated anemia: North Central Cancer Treatment Group (NCCTG) Study N02C2

P. Novotny, J. Sloan, C. Loprinzi, 2005 .

Symptom control trials: a 20-year experience.

L. Minasian, P. Novotny, J. Sloan, 2007, The journal of supportive oncology.

Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.

E. Perez, T. Rummans, P. Novotny, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lack of effect of coumarin in women with lymphedema after treatment for breast cancer.

P. Novotny, J. Sloan, C. Loprinzi, 1999, The New England journal of medicine.

Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.

P. Novotny, J. Sloan, C. Loprinzi, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III double‐blind, placebo‐controlled study of gabapentin for the prevention of delayed chemotherapy‐induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance)

J. Sloan, C. Loprinzi, L. Kottschade, 2014, Cancer.

Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial.

P. Novotny, J. Sloan, J. Mailliard, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients.

T. Cascino, J. Sloan, C. Loprinzi, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.

J. Sloan, C. Loprinzi, M. Law, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improving the quality of life of geriatric cancer patients with a structured multidisciplinary intervention: A randomized controlled trial

P. Brown, M. Clark, T. Rummans, 2007, Palliative and Supportive Care.

Analyzing Quality of Life ( QOL ) Endpoints in Clinical Trials via the SAS System

P. Novotny, J. Sloan, C. Loprinzi, 1998 .

Improving Spiritual Well-Being in Patients with Lung Cancers

M. Clark, C. Patten, T. Rummans, 2015, The journal of pastoral care & counseling : JPCC.

Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia.

P. Novotny, J. Sloan, C. Loprinzi, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Newer antidepressants for hot flashes-should their efficacy still be up for debate?

P. Novotny, J. Sloan, C. Loprinzi, 2009, Menopause.

Limited Sampling Models for Irinotecan Pharmacokinetics

J. Sloan, H. Pitot, C. Erlichman, 1999 .

Effect of intravenous calcium and magnesium (IV CaMg) on oxaliplatin-induced sensory neurotoxicity (sNT) in adjuvant colon cancer: Results of the phase III placebo-controlled, double-blind NCCTG trial N04C7

P. Novotny, J. Sloan, C. Loprinzi, 2008 .

Tetracycline to prevent epidermal growth factor receptor inhibitor‐induced skin rashes

P. Novotny, J. Sloan, C. Loprinzi, 2008, Cancer.

Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis.

J. Sloan, C. Loprinzi, S. Schild, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

1044 Phase III evaluation of sucralfate for radiation-induced esophagitis

P. Novotny, J. Sloan, C. Loprinzi, 1996 .

Pilot Evaluation of Black Cohosh for the Treatment of Hot Flashes in Women

P. Novotny, J. Sloan, C. Loprinzi, 2004, Cancer investigation.

Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia

J. Sloan, C. Loprinzi, A. Jatoi, 2001, Cancer.

Colorectal Tumour Microsatellite Instability Test Results: Perspectives from Patients

D. Bowen, S. Thibodeau, J. Sloan, 2004, Hereditary cancer in clinical practice.

Dehydroepiandrosterone for the treatment of hot flashes: a pilot study.

T. Rummans, T. Shanafelt, P. Carpenter, 2006, Supportive cancer therapy.

A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy‐associated anemia

P. Novotny, J. Sloan, D. Moore, 2015, American journal of hematology.

Phase III clinical trial evaluating low-molecular weight heparin (LMWH) in patients with advanced cancer: A North Central Cancer Treatment Group study

P. Novotny, J. Sloan, C. Loprinzi, 2005 .

A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA.

J. Sloan, D. Moore, C. Loprinzi, 2011, The journal of supportive oncology.

A Phase III Randomized, Double Blind, Placebo-Controlled Study of Pilocarpine for Vaginal Dryness: NCCTG study N04CA 1

J. Sloan, C. Loprinzi, R. Zon, 2011 .

Does tetracycline prevent/palliate epidermal growth factor receptor (EGFR) inhibitor-induced rash? A phase III trial from the North Central Cancer Treatment Group (N03CB)

P. Novotny, J. Sloan, C. Loprinzi, 2007 .

Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.

E. Perez, S. Antolak, P. Novotny, 1999, The Journal of urology.

' Phase J, study of the matrix metalloproteinase inhibitor, BAY 12-956^

J. Sloan, R. Goldberg, S. Alberts, 2001 .

Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy.

Randy L. Moore, G. E. Meyers, P. Novotny, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I II D ouble-Blind S tudy o f G lutamine V ersus P lacebo f or the P revention o f A cute D iarrhea i n P atients R eceiving P elvic Radiation T herapy

Randy L. Moore, G. E. Meyers, P. Novotny, 2003 .

Do Missing Values Influence Outcomes in a Cross-sectional Mail Survey?

D. Schroeder, P. Novotny, J. Sloan, 2021, Mayo Clinic proceedings. Innovations, quality & outcomes.

Pilot evaluation of citalopram for the relief of hot flashes.

T. Rummans, T. Shanafelt, P. Novotny, 2003, The journal of supportive oncology.

Measures of Completeness and Accuracy of Clinical Information in Skin Biopsy Requisition Forms: An Analysis of 249 Cases.

P. Novotny, J. Sloan, N. Comfere, 2016, American journal of clinical pathology.

Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer.

J. Jett, J. Sloan, R. Morton, 1999, American journal of clinical oncology.

Pilot evaluation of paroxetine for treating hot flashes in men.

P. Novotny, J. Sloan, C. Loprinzi, 2004, Mayo Clinic proceedings.

Phase III evaluation of fluoxetine for treatment of hot flashes.

E. Perez, T. Rummans, P. Novotny, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.

T. Rummans, T. Shanafelt, J. Sloan, 2005, Journal of palliative medicine.

On appetite and its loss.

J. Sloan, Shaji K. Kumar, A. Jatoi, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

THE ART OF ONCOLOGY: WHEN THE TUMOR IS NOT THE TARGET On A ppetite a nd I ts L oss

J. Sloan, Shaji K. Kumar, A. Jatoi, 2000 .

N03CC—a randomized, controlled, open-label trial of upfront vs. delayed zoledronic acid for prevention of bone loss in postmenopausal (PM) women with primary breast cancer (PBC) starting letrozole after tamoxifen

E. Perez, J. Sloan, C. Loprinzi, 2008 .

N02C1: A phase III randomized, placebo-controlled, double-blind trial of risedronate for prevention of bone loss in premenopausal women undergoing adjuvant chemotherapy for breast cancer (BC)

E. Perez, J. Sloan, C. Loprinzi, 2008 .

Randomized controlled trial of acitretin versus placebo in patients at high‐risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251)

P. Novotny, J. Sloan, C. Loprinzi, 2012, Cancer.

Evaluation of shark cartilage in patients with advanced cancer

Debra L Barton, Dennis F. Moore, J. Sloan, 2005, Cancer.

Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA

J. Sloan, C. Loprinzi, B. Bauer, 2010, Supportive Care in Cancer.

Pilot evaluation of flaxseed for the management of hot flashes.

P. Novotny, J. Sloan, C. Loprinzi, 2007, Journal of the Society for Integrative Oncology.

Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.

P. Novotny, J. Sloan, C. Loprinzi, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy

G. Y. Wong, P. Novotny, G. Wong, 2008, Cancer.

The burden of fatigue and quality of life in myeloproliferative disorders (MPDs)

J. Sloan, S. Verstovsek, M. Wadleigh, 2007, Cancer.

Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States

R. Hurt, P. Novotny, J. Sloan, 2009, Journal of public health.

Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.

R. Hurt, P. Novotny, J. Sloan, 2007, Mayo Clinic proceedings.

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.

P. Novotny, J. Sloan, C. Loprinzi, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study.

G. Y. Wong, M. Choti, K. Ahrar, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Flutamide in Men with Prostatic Intraepithelial Neoplasia: A Randomized, Placebo-Controlled Chemoprevention Trial

D. Bostwick, M. Blute, P. Novotny, 2006, American journal of therapeutics.

Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance])

J. Sloan, C. Loprinzi, T. Sio, 2016, Supportive Care in Cancer.

Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation.

G. Y. Wong, P. Novotny, G. Wong, 2002, Radiology.

Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study Approach

D. Schaid, C. Vachon, J. Olson, 2021, Cancers.

Methodologic lessons learned from hot flash studies.

P. Novotny, J. Sloan, C. Loprinzi, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

Debra L Barton, T. Rummans, P. Novotny, 2000, The Lancet.

Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma.

J. Jett, J. Sloan, R. Marks, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I II C omparison o f T wice-Daily S plit-Course Irradiation V ersus O nce-Daily I rradiation f or P atients With L imited S tage S mall-Cell L ung C arcinoma

J. Jett, J. Sloan, R. Marks, 1999 .

Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial.

P. Novotny, J. Sloan, C. Loprinzi, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer.

David P Steensma, P. Novotny, J. Sloan, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic Predictors of Chemotherapy-Induced Peripheral Neuropathy from Paclitaxel, Carboplatin and Oxaliplatin: NCCTG/Alliance N08C1, N08CA and N08CB Study

D. Schaid, C. Vachon, J. Olson, 2021, Cancers.

Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)

A. Abyzov, J. Sloan, C. Loprinzi, 2016, Cancer medicine.

Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance)

J. Sloan, C. Loprinzi, T. Dockter, 2018, Supportive Care in Cancer.

Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy

G. Y. Wong, P. Novotny, G. Wong, 2007, Cancer.

A phase III double blinded, placebo controlled, randomized trial of gabapentin in patients with chemotherapy-induced peripheral neuropathy: A North Central Cancer Treatment Group study

G. Y. Wong, P. Novotny, G. Wong, 2005 .

Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.

T. Sellers, L. Hartmann, J. Donohue, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients

J. Jett, P. Novotny, J. Sloan, 2004, Supportive Care in Cancer.

Are chemotherapy response rates related to treatment-induced survival prolongations in patients with advanced cancer?

T. Shanafelt, P. Novotny, J. Sloan, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysis.

G. Y. Wong, P. Novotny, G. Wong, 2006, Radiology.

Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.

E. Perez, E. Shaw, J. Sloan, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma

E. Shaw, J. Sloan, E. Creagan, 1998, Cancer.

Quantifying the importance of disease burden on perceived general health and depressive symptoms in patients within the Mayo Clinic Biobank

Suzette J. Bielinski, Jyotishman Pathak, Euijung Ryu, 2015, Health and Quality of Life Outcomes.

Can the Gail model be useful in American Indian and Alaska Native populations?

P. Novotny, J. Sloan, M. Roubidoux, 2004, Cancer.

Correlates of mammogram density in southwestern Native-American women.

K. Griffith, P. Novotny, J. Sloan, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

What Happened to All the Patients? Event Charts for Summarizing Individual Patient Data and Displaying Clinically Significant Changes in Quality of Life Data

Cristine Allmer, P. Novotny, J. Sloan, 2003 .

Phase III double-blinded, randomized trial to evaluate the use of black cohosh in the treatment of hot flashes: A North Central Cancer Treatment Group study

P. Novotny, J. Sloan, C. Loprinzi, 2005 .

Percutaneous image‐guided cryoablation of painful metastases involving bone

P. Novotny, S. Solomon, J. Sloan, 2013, Cancer.

Glutamine does not prevent paclitaxel-associated myalgias and arthralgias.

P. Novotny, J. Sloan, C. Loprinzi, 2003, The journal of supportive oncology.

A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors.

J. Sloan, R. Goldberg, H. Pitot, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Serum hepcidin levels predict response to intravenous iron and darbepoetin in chemotherapy-associated anemia.

J. Sloan, C. Loprinzi, D. Steensma, 2015, Blood.

Venlafaxine for the control of hot flashes: results of a longitudinal continuation study.

P. Novotny, J. Sloan, C. Loprinzi, 2002, Oncology nursing forum.

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.

J. Sloan, R. Goldberg, S. Alberts, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.

P. Novotny, J. Sloan, N. Macdonald, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.

P. Carpenter, J. Sloan, C. Loprinzi, 2007, Journal of the National Cancer Institute.

Dronabinol V ersus M egestrol A cetate V ersus C ombination Therapy f or C ancer-Associate d A norexia: A N orth C entral Cancer T reatment G roup S tudy

P. Novotny, J. Sloan, C. Loprinzi, 2002 .

Randomized C omparison o f M egestrol A cetate V ersus Dexamethasone V ersus F luoxymesterone f or t he Treatment o f C ancer A norexia/Cachexi a

P. Novotny, J. Sloan, C. Loprinzi, 1999 .

Treatment trade‐offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies

J. Sloan, A. Harris, J. Tilburt, 2013, Cancer.

A Phase I and Pharmacologic Study of Pyrazoloacridine (NSC 366140) and Carboplatin in Patients with Advanced Cancer

J. Sloan, R. Goldberg, S. Alberts, 2002, Investigational New Drugs.

Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma.

D. Sargent, J. Sloan, R. Goldberg, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy a nd Q uality-of-Life D ata A re R elated i n a P hase I I Trial o f O ral C hemotherapy i n P reviously U ntreated P atients With M etastatic C olorectal C arcinoma

D. Sargent, J. Sloan, R. Goldberg, 2002 .

A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin

J. Sloan, S. Alberts, C. Erlichman, 2005, Anti-cancer drugs.

Second response to the letter to the editor referencing the manuscript the “Use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial”

J. Sloan, C. Loprinzi, L. Kottschade, 2011, Supportive Care in Cancer.

Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial.

J. Sloan, C. Loprinzi, S. Dakhil, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient‐physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer

J. Sloan, C. Loprinzi, M. Mori, 2008, Cancer.

A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials

J. Jett, S. Mandrekar, J. Sloan, 2007, Cancer.

A Phase II Study of the Dolastatin 15 Analogue LU 103793 in the Treatment of Advanced Non–Small-Cell Lung Cancer

J. Sloan, S. Hillman, R. Marks, 2003, American journal of clinical oncology.

Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes

T. Therneau, A. Abyzov, J. Sloan, 2020, Journal of the Neurological Sciences.

Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB)

G. Wong, J. Sloan, C. Loprinzi, 2009, Supportive Care in Cancer.

Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation

P. Novotny, J. Sloan, C. Loprinzi, 2001, Supportive Care in Cancer.

Forecasting COPD hospitalization in the clinic: optimizing the chronic respiratory questionnaire

C. Karpman, P. Novotny, R. Benzo, 2015, International journal of chronic obstructive pulmonary disease.

Coumarin-induced hepatotoxicity.

J. Sloan, C. Loprinzi, J. Kugler, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Therapeutic Exercise during Outpatient Radiation Therapy for Advanced Cancer: Feasibility and Impact on Physical Well-Being

P. Brown, T. Rummans, J. Sloan, 2010, American journal of physical medicine & rehabilitation.

A novel approach of longitudinal adverse event evaluation in oncology clinical trials: the Toxicity over Time (ToxT) analysis of clinical trials N9741 and 979254 (Alliance)

P. Novotny, J. Sloan, C. Loprinzi, 2016, The Lancet. Oncology.

Healthy Immigrant Families: Randomized Controlled Trial of a Family-Based Nutrition and Physical Activity Intervention

Jennifer A. Weis, I. Sia, M. Wieland, 2018, American journal of health promotion : AJHP.

Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB)

P. Novotny, J. Sloan, C. Loprinzi, 2011, Supportive Care in Cancer.

A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial

J. Sloan, D. Moore, C. Loprinzi, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial

P. Novotny, J. Sloan, C. Loprinzi, 2004, Supportive Care in Cancer.

Is ATP (adenosine 5'-triphosphate), like STP, a performance-enhancing additive for the tanks of cancer patients?

J. Sloan, R. Goldberg, C. Loprinzi, 2000, Journal of the National Cancer Institute.

Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis.

P. Novotny, A. Vincent, J. Sloan, 2012, International journal of radiation oncology, biology, physics.

Score equivalence of paper-, tablet-, and interactive voice response system-based versions of PROMIS, PRO-CTCAE, and numerical rating scales among cancer patients

P. Novotny, D. Eton, J. Sloan, 2021, Journal of Patient-Reported Outcomes.

Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.

P. Novotny, J. Sloan, S. West, 2006, Ophthalmology.

Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.

R. Hurt, P. Novotny, J. Sloan, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nicotine P atch T herapy B ased o n S moking R ate F ollowed b y Bupropion f or P revention o f R elapse t o S moking

R. Hurt, P. Novotny, J. Sloan, 2003 .

The prevalence of weight concerns in a smoking abstinence clinical trial.

M. Clark, C. Patten, R. Hurt, 2006, Addictive behaviors.

Spiritual well-being and quality of life of women with ovarian cancer and their spouses.

J. Sloan, K. Burger, M. Frost, 2012, The journal of supportive oncology.

The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5).

J. Sloan, D. Moore, C. Loprinzi, 2011, The journal of supportive oncology.

Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer.

Muhammad Salim, Mark D. Carlson, E. Perez, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation‐induced mucositis

P. Novotny, J. Sloan, C. Loprinzi, 1997, Cancer.

Tobacco assessment in completed lung cancer treatment trials

J. Sloan, G. Warren, Erica N Peters, 2016, Cancer.

Paced breathing compared with usual breathing for hot flashes

J. Sloan, C. Loprinzi, D. Satele, 2012, Menopause.

Quality of life measurements: a soft outcome--or is it?

J. Sloan, M. Frost, 2002, The American journal of managed care.

Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma: A Phase 3 Randomized Clinical Trial.

P. Brown, M. Mehta, J. Sloan, 2021, JAMA oncology.

Pilot Feasibility Study of a Digital Storytelling Intervention for Immigrant and Refugee Adults With Diabetes

B. Yawn, I. Sia, M. Wieland, 2017, The Diabetes educator.

Quality of life (QOL) for patients treated with FOLFOX with or without cetuximab (Cmab) following complete resection of colorectal cancer (CRC): Results from North Central Cancer Treatment Group (NCCTG) phase III trial N0147.

D. Sargent, J. Sloan, R. Goldberg, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeting and palliating malignant ascites: an overview of an upcoming clinical trial from the north central cancer treatment group.

L. Hartmann, J. Sloan, A. Jatoi, 2005, Supportive cancer therapy.

Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer

P. Brown, M. Clark, T. Rummans, 2013, Cancer.

Population pharmacokinetic model for irinotecan and two of its metabolites, SN‐38 and SN‐38 glucuronide

Mark J Ratain, M. Ratain, J. Sloan, 2002, Clinical pharmacology and therapeutics.

DESIGN AND ANALYSIS OF CANCER CONTROL STUDIES USING THE SAS SYSTEM

P. Novotny, J. Sloan, C. Loprinzi, 2000 .

Response to letter to the editor referencing manuscript the “Use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial”

J. Sloan, C. Loprinzi, L. Kottschade, 2011, Supportive Care in Cancer.

Phase III double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea during pelvic radiation therapy: Results of North Central Cancer Treatment Group protocol N00CA.

J. Sloan, R. Miller, D. Wender, 2006, Journal of Clinical Oncology.

Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy.

P. Novotny, J. Sloan, C. Loprinzi, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationship Between Negative Mood and Health Behaviors in an Immigrant and Refugee Population

I. Sia, M. Wieland, M. Clark, 2017, Journal of Immigrant and Minority Health.

Relationship of mammographic parenchymal patterns to breast cancer risk factors and smoking in Alaska Native women.

Multicenter derivation and validation of an early warning score for acute respiratory failure or death in the hospital

Vitaly Herasevich, Ognjen Gajic, Mikhail A. Dziadzko, 2018, Critical Care.

End-of-life care in a population-based cohort of cancer patients: clinical trial participation versus standard of care

T. Shanafelt, P. Novotny, J. Sloan, 2013, BMJ Supportive & Palliative Care.

A phase III trial evaluating three doses of citalopram for hot flashes: NCCTG trial N05C9

J. Sloan, C. Loprinzi, S. Dakhil, 2008 .

Does efficacy of non-estrogenic therapies for hot flashes among women vary by breast cancer history and tamoxifen use? A pooled analysis

P. Novotny, A. Bardia, J. Sloan, 2008 .

A pilot, multi-dose, placebo-controlled evaluation of american ginseng (panax quinquefolius) to improve cancer-related fatigue: NCCTG trial N03CA

J. Sloan, C. Loprinzi, B. Bauer, 2007 .

The efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: A phase III randomized, double blind, placebo-controlled NCCTG trial, N01C3.

P. Novotny, G. Wong, J. Sloan, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Changes in Ovarian Stromal Function in Premenopausal Women Undergoing Chemotherapy for Breast Cancer

J. Sloan, C. Loprinzi, M. Frost, 2004 .

Wherefore global quality-of-life assessment? [6] (multiple letters)

M. Somerfield, J. Sloan, C. Loprinzi, 1999 .

Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance)

E. Perez, P. Novotny, J. Singh, 2015, Osteoporosis International.

Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD)

J. Buckner, D. Petereit, E. Basch, 2021, Cancer.

Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials

J. Sloan, J. Unger, M. Bakitas, 2021, JCO oncology practice.

Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer

P. Novotny, J. Sloan, C. Fuchs, 2023, Cancer control : journal of the Moffitt Cancer Center.

Graphical and Analytical Tools for the Analysis of Two-Period Crossover Clinical Trials

P. Novotny, J. Sloan, C. Loprinzi, 1997 .

A GENERAL GIBBS SAMPLING ALGORITHM FOR ANALYZING LINEAR MODELS USING THE SAS SYSTEM

D. Sargent, P. Novotny, J. Sloan, 1999 .

A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation On the Erythropoietic Response to Darbepoetin Alfa for Patients with Chemotherapy-Associated Anemia: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC).

P. Novotny, J. Sloan, C. Loprinzi, 2009 .

Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer.

J. O'fallon, I. Heid, J. Sloan, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)

H. Cohen, D. Berry, E. Winer, 2016, Breast Cancer Research and Treatment.

Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States

P. Novotny, J. Sloan, C. Loprinzi, 2009, Journal of Public Health.

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

L. Hartmann, J. Sloan, J. Sloan, 2010, Cancer research.

A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity.

W. R. Bishop, J. Sloan, J. Sloan, 2000, Cancer research.

Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas

J. Sloan, J. Sloan, E. Galanis, 2005, Gene Therapy.

Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.

J. Sloan, J. Sloan, R. Goldberg, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

O-73 High dose, twice-daily thoracic radiotherapy (TRT) with daily chemotherapy in limited stage small cell lung cancer

J. Jett, J. Sloan, S. Hillman, 2003 .

Treatment decision making in women newly diagnosed with breast cancer.

J. Sloan, J. Sloan, R. Owens, 1996, Cancer nursing.

Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs

R. Petersen, J. Sloan, A. Jatoi, 2004, Supportive Care in Cancer.

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

L. Hartmann, J. Sloan, E. Galanis, 2010, Cancer research.

Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.

J. Sloan, R. Goldberg, H. Pitot, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Therapeutic Exercise during Outpatient Radiation Therapy for Advanced Cancer: Feasibility and Impact on Physical Well-Being

P. Brown, T. Rummans, J. Sloan, 2010, American journal of physical medicine & rehabilitation.

Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy.

E. Perez, J. Sloan, C. Loprinzi, 2010, Breast.

Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance)

D. Sargent, J. Singh, P. Novotny, 2018, International journal of statistics in medical research.